***** TODAY’S NEWS Hugely encouraging results for Novartis' new experimental (oral) MS treatment - Novartis’ Gilena has delivered an impressive performance in a Phase III trial in patients …
Impactiviti Daily 012110
TODAY’S NEWS Note: if you're going to engage in questionable marketing practices, documenting it in Powerpoint is probably not a "best practice"! Just saying... Experiment HIV drug from Merck fails …
Pharma News this week
General news: Approvals: Genzyme's stem cell transplant drug Mozobil; Abbott's triglyceride drug TriLipix; Eisai's Lusedra for anesthesia. Novartis' experimental MS drug (oral) looking really good …